Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/07/3105 : 13Business WireCalifornia American Water Signs Agreement to Purchase Yerba Buena Water Company’s AssetsNYSE:AWKAmerican Water Works
2024/07/3105 : 12Edgar (US Regulatory)Form 13F-NT - Quarterly report filed by institutional managers, NoticeUSOTC:INTAFIntact Financial Corporation (PK)
2024/07/3105 : 12Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:VXXiPath Series B S&P 500 VIX ShortTerm Futures ETN
2024/07/3105 : 12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSGPCoStar Group Inc
2024/07/3105 : 12Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:FBGXUBS AG FI Enhanced Large Cap Growth
2024/07/3105 : 12Edgar (US Regulatory)Form 13F-HR - Quarterly report filed by institutional managers, HoldingsNASDAQ:AMZNAmazon.com Inc
2024/07/3105 : 12Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:FBGXUBS AG FI Enhanced Large Cap Growth
2024/07/3105 : 12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WGSGeneDx Holdings Corporation
2024/07/3105 : 12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSGPCoStar Group Inc
2024/07/3105 : 12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:UHSUniversal Health Services
2024/07/3105 : 12Edgar (US Regulatory)Form 8-K - Current reportNYSE:BAHBooz Allen Hamilton Holding Corporation
2024/07/3105 : 12Business WireBiogen, Beckman Coulter und Fujirebio arbeiten gemeinsam an blutbasierten Biomarkern und Tests für Tau-Pathologie bei Alzheimer-Krankheit
2024/07/3105 : 12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NARIInari Medical Inc
2024/07/3105 : 12Business WireBiogen, Beckman Coulter et Fujirebio collaboreront sur les biomarqueurs sanguins et les tests de la pathologie tau dans la maladie d’Alzheimer
2024/07/3105 : 12PR Newswire (US)Terex Reports Strong Second Quarter 2024 ResultsNYSE:TEXTerex Corp
2024/07/3105 : 11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSGPCoStar Group Inc
2024/07/3105 : 11Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:FBGXUBS AG FI Enhanced Large Cap Growth
2024/07/3105 : 11Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPM-MJP Morgan Chase and Co
2024/07/3105 : 11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:CCICrown Castle Inc
2024/07/3105 : 11GlobeNewswire Inc.A21 Releases 2023 Global and Regional Impact Reports on World Day Against Trafficking
2024/07/3105 : 11Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:FBGXUBS AG FI Enhanced Large Cap Growth
2024/07/3105 : 11Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:FBGXUBS AG FI Enhanced Large Cap Growth
2024/07/3105 : 11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EFXEquifax Inc
2024/07/3105 : 11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRVGtrivago NV
2024/07/3105 : 11Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:VXXiPath Series B S&P 500 VIX ShortTerm Futures ETN
2024/07/3105 : 11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EFXEquifax Inc
2024/07/3105 : 11Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPM-MJP Morgan Chase and Co
2024/07/3105 : 11Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementUSOTC:EFTReFFECTOR Therapeutics Inc (PK)
2024/07/3105 : 11Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPM-MJP Morgan Chase and Co
2024/07/3105 : 11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EAElectronic Arts Inc